Medpace Holdings, Inc. (MEDP) stock
MEDPNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 22, 2026Score 14/3042% above fair value
$646.87−6.22 (-0.95%)
Close on Nov 18, 2026Market cap $18.09BP/E 35.9Yield –
Medpace r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for Medpace
Medpace has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?